US Patent Issued to Ferring on Jan. 27 for "Methods of treating prostate cancer with GnRH antagonist" (Danish, Swedish, American, Swiss Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,387, issued on Jan. 27, was assigned to Ferring B.V. (Hoofddorp, Netherlands).

"Methods of treating prostate cancer with GnRH antagonist" was invented by Tine Kold Olesen (New York), Bo-Eric Persson (St. Prex, Switzerland), Per Cantor (Charlottenlund, Denmark), Egbert A. van der Meulen (Dalby, Sweden) and Jens-Kristian Slott Jensen (Bagsvaerd, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist...